Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (75)
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200
Price
$13.95
Total Value
$2.79K
Shares Held After
910,143
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
100
Price
$13.80
Total Value
$1.38K
Shares Held After
909,943
% of Holdings
0.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,100
Price
$1.02
Total Value
$5.20K
Shares Held After
285,866
% of Holdings
1.8%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
75,178
Price
$14.00
Total Value
$1.05M
Shares Held After
909,843
% of Holdings
8.3%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
4,081
Price
$13.80
Total Value
$56.31K
Shares Held After
834,665
% of Holdings
0.5%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,937
Price
$66.87
Total Value
$129.53K
Shares Held After
488,437
% of Holdings
0.4%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
100,000
Price
$1.19
Total Value
$119.00K
Shares Held After
222,497
% of Holdings
44.9%
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
37,453
Price
$5.36
Total Value
$200.75K
Shares Held After
232,308
% of Holdings
16.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,500
Price
$67.98
Total Value
$101.97K
Shares Held After
486,500
% of Holdings
0.3%
Lantern Pharma Inc. (LTRN)
KEYSER D JEFFREY — Director
Shares
48,544
Price
$2.06
Total Value
$100.00K
Shares Held After
94,303
% of Holdings
51.5%
Lantern Pharma Inc. (LTRN)
Schalop Lee Troy — Director
Shares
48,544
Price
$2.06
Total Value
$100.00K
Shares Held After
48,544
% of Holdings
100.0%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
12,500
Price
$8.01
Total Value
$100.12K
Shares Held After
513,884
% of Holdings
2.4%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
800
Price
$13.83
Total Value
$11.06K
Shares Held After
830,584
% of Holdings
0.1%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
19,900
Price
$14.00
Total Value
$278.60K
Shares Held After
829,784
% of Holdings
2.4%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$14.00
Total Value
$350.00K
Shares Held After
809,884
% of Holdings
3.1%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
5,100
Price
$14.00
Total Value
$71.39K
Shares Held After
784,884
% of Holdings
0.6%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
6,510,416
Price
$11.52
Total Value
$75.00M
Shares Held After
15,203,995
% of Holdings
42.8%
Viridian Therapeutics, Inc.\DE (VRDN)
Fairmount Funds Management LLC — Director
Shares
1,176,470
Price
$17.00
Total Value
$20.00M
Shares Held After
5,090,928
% of Holdings
23.1%
Annexon, Inc. (ANNX)
Carson William H. — Director
Shares
8,000
Price
$5.78
Total Value
$46.24K
Shares Held After
78,405
% of Holdings
10.2%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
12,500
Price
$8.01
Total Value
$100.12K
Shares Held After
501,384
% of Holdings
2.5%
Caris Life Sciences, Inc. (CAI)
Vacirca Jeff L — Director
Shares
31,050
Price
$16.15
Total Value
$501.43K
Shares Held After
49,671
% of Holdings
62.5%
Cellectar Biosciences, Inc. (CLRB)
CARUSO JAMES V — Director
Shares
8,680
Price
$2.88
Total Value
$25.00K
Shares Held After
20,318
% of Holdings
42.7%
Cellectar Biosciences, Inc. (CLRB)
Longcor Jarrod — Chief Operating Officer
Shares
8,680
Price
$2.88
Total Value
$25.00K
Shares Held After
20,451
% of Holdings
42.4%
Atara Biotherapeutics, Inc. (ATRA)
EcoR1 Capital, LLC — 10% Owner
Shares
507,407
Price
$9.35
Total Value
$4.74M
Shares Held After
1,552,000
% of Holdings
32.7%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
129
Price
$1.70
Total Value
$219.30
Shares Held After
829
% of Holdings
15.6%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
35,101
Price
$14.00
Total Value
$491.26K
Shares Held After
779,784
% of Holdings
4.5%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
116,904
Price
$13.97
Total Value
$1.63M
Shares Held After
744,683
% of Holdings
15.7%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,900
Price
$13.90
Total Value
$54.20K
Shares Held After
627,779
% of Holdings
0.6%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.16
Total Value
$41.59K
Shares Held After
3,072,000
% of Holdings
0.3%
Rein Therapeutics, Inc. (RNTX)
WINDSOR JAMES BRIAN — Director
Shares
25,000
Price
$1.00
Total Value
$25.00K
Shares Held After
27,046
% of Holdings
92.4%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,511
Price
$2.69
Total Value
$4.06K
Shares Held After
6,236
% of Holdings
24.2%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,034
Price
$2.69
Total Value
$5.47K
Shares Held After
6,013
% of Holdings
33.8%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,190
Price
$2.69
Total Value
$5.89K
Shares Held After
6,498
% of Holdings
33.7%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,748
Price
$2.69
Total Value
$4.70K
Shares Held After
6,441
% of Holdings
27.1%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,706
Price
$2.69
Total Value
$4.59K
Shares Held After
13,813
% of Holdings
12.4%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
200
Price
$1.68
Total Value
$336.00
Shares Held After
700
% of Holdings
28.6%
Processa Pharmaceuticals, Inc. (PCSA)
Bigora Sian — Chief Development Officer
Shares
1,986
Price
$2.69
Total Value
$5.34K
Shares Held After
7,496
% of Holdings
26.5%
Telix Pharmaceuticals Ltd (TLX)
Behrenbruch Christian — Director
Shares
33,435
Price
$14.87
Total Value
$497.18K
Shares Held After
20,742,935
% of Holdings
0.2%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
100
Price
$1.75
Total Value
$175.00
Shares Held After
500
% of Holdings
20.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$1.11
Total Value
$5.55K
Shares Held After
280,766
% of Holdings
1.8%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
35,000
Price
$17.62
Total Value
$616.70K
Shares Held After
1,786,039
% of Holdings
2.0%
Telix Pharmaceuticals Ltd (TLX)
Behrenbruch Christian — Director
Shares
34,500
Price
$14.48
Total Value
$499.56K
Shares Held After
20,709,500
% of Holdings
0.2%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
25,000
Price
$18.02
Total Value
$450.50K
Shares Held After
1,751,039
% of Holdings
1.4%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.52
Total Value
$45.18K
Shares Held After
3,062,000
% of Holdings
0.3%
NewcelX Ltd. (NCEL)
Samuel Olivier — Director
Shares
81,818
Price
$2.75
Total Value
$225.00K
Shares Held After
81,818
% of Holdings
100.0%
NewcelX Ltd. (NCEL)
Revel Michel — Director
Shares
54,545
Price
$2.75
Total Value
$150.00K
Shares Held After
957,530
% of Holdings
5.7%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
250,923
Price
$3.64
Total Value
$913.13K
Shares Held After
12,684,884
% of Holdings
2.0%
NovaBridge Biosciences (NBP)
Hagler Mark Arnold — President and Chief Commercial Officer
Shares
230,000
Price
$2.51
Total Value
$577.30K
Shares Held After
230,000
% of Holdings
100.0%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
38,880
Price
$3.53
Total Value
$137.08K
Shares Held After
12,433,961
% of Holdings
0.3%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
280,381
Price
$3.50
Total Value
$982.03K
Shares Held After
12,395,081
% of Holdings
2.3%
Showing 1–50 of 75 transactions (page 1 of 2)